No completed review is recorded for the full analysis. HBM revenue shares were checked against Counterpoint’s Q2 2026 table in September 2026; the DRAM figures were aligned with the concentration table without a new source check.
This page combines source data with specified disruption assumptions. Its estimates are calculated separately from the supply-chain cascade engine.
The newest input comes from the Q2 2026 HBM revenue shares (Counterpoint); the DRAM share figures, which include CXMT, are two quarters older, at Q4 2025. Review state for all five analyses is on the index.